...
首页> 外文期刊>Acta Crystallographica Section E: Crystallographic Communications >Crystal structure of (2-{[3,5-bis­(1,1-di­methyl­eth­yl)-4-hy­droxy­phen­yl](5-methyl-2H-pyrrol-2-yl­idene)meth­yl}-5-methyl-1H-pyrrolido-κ2N,N′)di­fluoridoboron
【24h】

Crystal structure of (2-{[3,5-bis­(1,1-di­methyl­eth­yl)-4-hy­droxy­phen­yl](5-methyl-2H-pyrrol-2-yl­idene)meth­yl}-5-methyl-1H-pyrrolido-κ2N,N′)di­fluoridoboron

机译:(2-{[3,5-双(1,1-二甲基乙基)-4-羟基苯基](5-甲基-2H-吡咯-2-亚甲基)甲基} -5-甲基-1H-吡咯烷-κ2N的晶体结构,N')二氟硼

获取原文
           

摘要

The title compound, C25H31BF2N2O, is a potential boron tracedrug in boron neutron capture therapy (BNCT), in which the B atom adopts a distorted BN2F2 tetra­hedral geometry: it is soluble in dimethyl sulfoxide, di­methyl­formamide and methanol. The pyrrolyl­idene­methyl­pyrrole triple fused ring system is almost planar (r.m.s. deviation = 0.031 Å) and subtends a dihedral angle of 47.09 (5)° with the plane of the pendant phenol ring. The phenol –OH group is blocked from forming hydrogen bonds by the adjacent bulky tert-butyl groups. In the crystal, inversion dimers linked by pairs of very weak C—H⋯F inter­actions generate R22(22) loops.
机译:标题化合物C25H31BF2N2O是硼中子俘获疗法(BNCT)中潜在的硼微量药物,其中B原子采用扭曲的BN2F2四面体几何形状:它可溶于二甲基亚砜,二甲基甲酰胺和甲醇。吡咯亚甲基甲基吡咯三稠环系统几乎是平面的(r.m.s.偏差= 0.031Å),与苯酚侧链的平面的二面角为47.09(5)°。酚-OH基团被相邻的大体积叔丁基基团阻止形成氢键。在晶体中,由非常弱的CHF相互作用对链接的反向二聚体会生成R22(22)环。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号